Who’s Liable for Bad Medical Advice in the Age of ChatGPT?
What are the risks of using generative AI systems like ChatGPT in medical practice, and who is ultimately held responsible for patient harm?
Medical Devices
-
Read more: Who’s Liable for Bad Medical Advice in the Age of ChatGPT? -
Read more: Could Self-Operated Assisted Suicide Devices Be Coming to a Town near You? Could Self-Operated Assisted Suicide Devices Be Coming to a Town near You?
This article considers both federal and state considerations around the legality of self-operated assisted suicide devices.
-
Read more: Get Your Story Straight: Patent Office Cracks Down on Inconsistent Statements Made Before the FDA Get Your Story Straight: Patent Office Cracks Down on Inconsistent Statements Made Before the FDA
While it may not seem controversial to promote honesty before the USPTO, a recent Federal Register Notice goes far beyond requiring candor.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of August 2021.
-
Read more: Should We Regulate Direct-to-Consumer Health Apps? Should We Regulate Direct-to-Consumer Health Apps?
Over 318,000 health apps are available in app stores, but only a fraction are regulated by the U.S. Food and Drug Administration.
-
Read more: Appeals Court Overturns FDA’s Partial Ban on Shock Devices: Analysis of Ruling Appeals Court Overturns FDA’s Partial Ban on Shock Devices: Analysis of Ruling
The court held that prohibiting electrical stimulation in some settings, but not others, runs afoul of a “practice of medicine” statutory provision.
-
Read more: Call for Abstracts — 2022 Petrie-Flom Center Annual Conference: Diagnosing in the Home Call for Abstracts — 2022 Petrie-Flom Center Annual Conference: Diagnosing in the Home
Contribute to the 2022 Petrie-Flom Center Annual Conference and subsequent book project!
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of March 2021.
-
Read more: Building Trust Through Transparency? FDA Regulation of AI/ML-Based Software Building Trust Through Transparency? FDA Regulation of AI/ML-Based Software
Individual algorithm explanations will likely do little to build trust among health care AI users.
-
Read more: Weaknesses in Medical Device Regulation Worsened by Trump Administration Weaknesses in Medical Device Regulation Worsened by Trump Administration
In the waning days of the Trump administration, a final push was made to fundamentally weaken regulation of medical devices.
